Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Allogene Therapeutics, Inc. | VP, Corporate Counsel | Common Stock | 140K | $446K | $3.17 | Apr 1, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALLO | Allogene Therapeutics, Inc. | Apr 1, 2023 | 1 | $0 | 4 | Apr 5, 2023 | VP, Corporate Counsel |
ALLO | Allogene Therapeutics, Inc. | Apr 1, 2023 | 0 | $0 | 3 | Apr 5, 2023 | VP, Corporate Counsel |